In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse calvaria

American Journal of Physiology - Endocrinology and Metabolism

Volumn 285, Issue 3 48-3, 2003, Pages

  Kondo, Ayami ^a   Togari, Akifumi ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Calvaria; Interleukin 6; Intracerebroventricular injection; Lipopolysaccharide; Osteoblast; Restraint stress; Sympathetic activity

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR; INTERLEUKIN 6; ISOPRENALINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NEUROTOXIN; NORADRENALIN; OXIDOPAMINE; PHENTOLAMINE; PROPRANOLOL;

ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE METABOLISM; CALVARIA; CELL ACTIVITY; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; MALE; MOUSE; NERVE ENDING; NONHUMAN; NORADRENERGIC SYSTEM; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; SYMPATHETIC NERVE; SYMPATHETIC TONE;

EID: 0041464534     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00026.2003     Document Type: Article

References (33)

1. Akiyoshi M, Shimizu Y, and Saito M. Interleukin-1 increases norepinephrine turnover in the spleen and lung in rats. Biochem Biophys Res Commun 173: 1266-1270, 1990.
2. Arcari P, Martinelli R, and Salvatore F. The complete sequence of a full length cDNA for humasn liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res 12: 9178-9189, 1984.
3. Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, and Herzog H. Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109: 915-921, 2002.
4. Bjurholm A. Neuroendocrine peptides in bone. Int Orthop 15: 325-329, 1991.
5. Bjurholm A, Kreicbergs A, Dahlberg L, and Schultzberg M. The occurrence of neuropeptides at different stages of DBM-induced heterotopic bone formation. Bone Miner 10: 95-107, 1990.
6. Cherruau M, Facchinetti P, Baroukh B, and Saffar JL. Chemical sympathectomy impairs bone resorption in rats: a role for the sympathetic system on bone metabolism. Bone 25: 545-551, 1999.
7. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
8. De Simoni MG, De Luigi A, Gemma L, Sironi M, Manfridi A, and Ghezzi P. Modulation of systemic interleukin-6 induction by central interleukin-1. Am J Physiol Endocrinol Metab 265: E739-E742, 1993.
9. De Simoni MG, Sironi M, De Luigi A, Manfridi A, Mantovani A, and Ghezzi P. Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6. J Exp Med 171: 1773-1778, 1990.
10. Dunn AJ. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J Pharmacol Exp Ther 261: 964-969, 1992.
11. Finck BN, Dantzer R, Kelley KW, Woods JA, and Johnson RW. Central lipopolysaccharide elevates plasma IL-6 concentration by an α-adrenoceptor-mediated mechanism. Am J Physiol Endocrinol Metab 272: E1880-E1887, 1997.
12. Grenett HE, Fuentes NL, and Fuller GM. Cloning and sequence analysis of the cDNA for murine interleukin-6 (Abstract). Nucleic Acids Res 18: 6455, 1990.
13. Haley TJ and McCormick WG. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol 12: 12-15, 1957.
14. Hill EL, Turner R, and Elde R. Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats. Neuroscience 44: 747-755, 1991.
15. Hohmann EL, Elde RP, Rysavy JA, Einzig S, and Gebhard RL. Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers. Science 232: 868-871, 1986.
16. Kondo A, Mogi M, Koshihara Y, and Togari A. Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochem Pharmacol 61: 319-326, 2001.
17. Kostrzewa RM and Jacobowitz DM. Pharmacological actions of 6-hydroxydopamine. Pharmacol Rev 26: 199-288, 1974.
18. LeMay LG, Otterness IG, Vander AJ, and Kluger MJ. In vivo evidence that the rise in plasma IL 6 following injection of a fever-inducing dose of LPS is mediated by IL 1 beta. Cytokine 2: 199-204, 1990.
19. Moore RE, Smith CK II, Bailey CS, Voelkel EF, and Tashijian AH. Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone. Bone Miner 23: 301-315, 1993.
20. Murammai N, Fukata J, Tsukada T, Kobayashi H, Ebisui O, Segawa H, Muro S, Imura H, and Nakao K. Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal grand, and spleen. Endocrinology 133: 2574-2578, 1993.
21. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, and Chrousos GP. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol Endocrinol Metab 271: E601-E605, 1996.
22. Roodman GD. Advances in bone biology: the osteoclast. Endocr Rev 17: 308-332, 1996.
23. Song DK, Im YB, Jung JS, Suh HW, Huh SO, Park SW, Wie MB, and Kim YH. Differential involvement of central and peripheral norepinephrine in the central lipopolysaccharide-induced interleukin-6 responses in mice. J Neurochem 72: 1625-1633, 1999.
24. Suda T, Takahashi N, and Martin TJ. Modulation of osteoclast differentiation. Endocr Rev 13: 66-80, 1992.
25. Suda T, Udagawa N, Nakamura I, Miyamura C, and Takahashi N. Modulation of osteoclast differentiation by local factors. Bone 17: 87S-91S, 1995.
26. Suzuki A, Palmer G, Bonjour JP, and Caverzasio J. Catecholamines stimulate the proliferation and alkaline phosphatase activity of MC3T3-E1 osteoblast-like cells. Bone 23: 197-203, 1998.
27. Takaki A, Huang QH, Somogyvari-Vigh A, and Arimura A. Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation 1: 335-342, 1994.
28. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, and Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell 111: 305-317, 2002.
29. Takeuchi T, Tsuboi T, Arai M, and Togari A. Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. Biochem Pharmacol 61: 579-586, 2001.
30. Togari A. Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech 58: 77-84, 2002.
31. Togari A, Arai M, Mizutani S, Mizutani S, Koshihara Y, and Nagatsu T. Expression of mRNAs for neuropeptide receptors and β-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci Lett 233: 125-128, 1997.
32. Togari A, Mogi M, Arai M, Yamamoto S, and Koshihara Y. Expression of mRNA for axon guidance molecules, such as semaphorin-III, netrins and neurotrophins, in human osteoblasts and osteoclasts. Brain Res 878: 204-209, 2000.
33. Zhou D, Kusnecov AW, Shurin MR, DePaoli M, and Rabin BS. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 133: 2523-2530, 1993.